Document Detail


Clinical course of arrhythmogenic right ventricular cardiomyopathy in the era of implantable cardioverter-defibrillators and radiofrequency catheter ablation.
MedLine Citation:
PMID:  20145349     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study investigated the clinical course of arrhythmogenic right ventricular cardiomyopathy (ARVC) patients and in particular evaluated the contribution of radiofrequency catheter ablation (RFCA) and an implantable cardioverter-defibrillator (ICD) to the treatment of ARVC. ARVC is a myocardial disorder and a cause of sudden cardiac death due to ventricular tachycardia (VT). Little is known about its prognosis in Japanese ARVC patients. Thirty-five ARVC patients were studied. Mean age of patients whose onset of ARVC was congestive heart failure (CHF) (66.0 +/- 4.0 years) was significantly higher than those whose onset was VT (44.5 +/- 14.8 years, P < 0.05). ARVC patients with CHF onset showed significantly higher death rates compared to those with VT onset. ICD treatment significantly reduced episodes of hospitalization due to VT (0.1 +/- 0.4 episodes) in comparison to treatment by RFCA (1.7 +/- 2.2 episodes, P < 0.03). RFCA treatment did not reduce recurrence of VT in the follow-up period. ICD therapy showed comparable mortality to RFCA treatment. The prognosis of ARVC with CHF onset is poor. ICD therapy significantly reduced hospitalization due to VT compared with RFCA treatment. ICD implantation in combination with medication may be a better treatment for ARVC.
Authors:
Masatoshi Komura; Jun-Ichi Suzuki; Susumu Adachi; Atsushi Takahashi; Kenichiro Otomo; Junichi Nitta; Mitsuhiro Nishizaki; Tohru Obayashi; Akihiko Nogami; Yasuhiro Satoh; Kaoru Okishige; Hitoshi Hachiya; Kenzo Hirao; Mitsuaki Isobe
Related Documents :
1743729 - Frequency analysis of the electrocardiogram with maximum entropy method for identificat...
20117059 - Focal mechanism of ventricular tachycardia in coronary artery disease.
11305989 - Long-term clinical outcome of patients with prior myocardial infarction after palliativ...
19465439 - Ventricular arrhythmias and sudden death in adults after a mustard operation for transp...
7479169 - Endocardial fragmented electrogram and prediction of ventricular tachycardia by body su...
6170769 - Identification of the site of origin of ventricular premature beats and its activation ...
2389839 - Do thallium myocardial perfusion scan abnormalities predict survival in sarcoid patient...
6785199 - Coronary bypass: the first 10 years.
7516549 - Histopathological changes following laser ablation of a left-sided accessory pathway in...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International heart journal     Volume:  51     ISSN:  1349-2365     ISO Abbreviation:  Int Heart J     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-02-10     Completed Date:  2010-03-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101244240     Medline TA:  Int Heart J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  34-40     Citation Subset:  IM    
Affiliation:
Department of Cardiovascular Medicine, Tokyo Medical and Dental University Hospital.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Anti-Arrhythmia Agents / therapeutic use
Arrhythmogenic Right Ventricular Dysplasia / complications*,  drug therapy,  surgery
Catheter Ablation*
Defibrillators, Implantable*
Female
Heart Failure / etiology*
Humans
Male
Middle Aged
Retrospective Studies
Tachycardia, Ventricular / etiology*,  therapy
Treatment Outcome
Young Adult
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High Homocysteine Levels Predict the Recurrence of Atrial Fibrillation After Successful Electrical C...
Next Document:  Long-Term Exercise-Training Improves QT Dispersion in the Metabolic Syndrome.